Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer

ConclusionUsing MS-GUIDE we identified fibronectin and vitronectin as candidate biomarkers for prostate cancer risk stratification.
Source: Clinical Proteomics - Category: Biochemistry Source Type: research